Adoption is MedTech’s most discussed word — and the least measured.
Why Muller Advisory
Adoption does not happen inside the MedTech company alone. It also depends on what occurs inside the healthcare organization evaluating, purchasing, implementing, and using the technology.
Having worked on both sides of that decision, we understand how evidence, workflow, stakeholder priorities, financial logic, and commercial execution must come together for a technology to become part of routine care.
We understand what must happen inside both the MedTech company and the healthcare system for a new technology to become part of routine care.
Our Vision
We envision a MedTech market in which adoption readiness is evaluated as deliberately as regulatory, clinical, and financial readiness.
The MedTech Adoption Architecture™ and /45 Adoption Readiness™ Score help leadership teams make adoption risk visible, prioritize the conditions that must be built, and direct capital and resources where they matter most.
Through diagnostic insight, commercial architecture, and embedded fractional leadership, Muller Advisory helps transform adoption from an ambiguous ambition into something leaders can evaluate, prioritize, build, and manage.
Our perspective
Adoption must work on both sides of the market.
Inside a healthcare organization, adoption depends on more than clinical evidence or physician enthusiasm. Financial justification, workflow feasibility, stakeholder alignment, operational capacity, and the technology’s ability to deliver value under real-world constraints all influence the decision.
Inside a MedTech company, those requirements must be translated into positioning, market access, stakeholder strategy, sales enablement, and disciplined commercial execution.
Muller Advisory Company understands both sides—and helps leadership teams build the commercial architecture that connects them.
Every engagement begins with a conversation. Where are you on the adoption journey?
Let's Talk